Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2019

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Medtech Market Intelligence

To succeed in medtech, you need to have your finger on the pulse – but accurate, reliable information is not always easy to find. We can help you get what you need.

Accurate expert analysis for a fragmented market

timely news deep insight pharma intelligence

Fast growth in the medical technology market is driven by innovation, demographic shifts, cost-efficient development and increased M&A activity. Success in this arena depends on your ability to bring cutting-edge solutions to the fore quickly, and having accurate intelligence is crucial for a sound development strategy.

How we help

Our medtech market intelligence will keep you up-to-date with important events and help you anticipate future technology needs – so you can evaluate new market opportunities and make confident business decisions.

Find comprehensive and accurate information on devices/diagnostics that compete in your markets
Stay abreast of important current events in our space that will affect your business
Rapidly find information on opportunities or targets within the medtech arena
Stay up to date with new trends and innovation in order to evaluate opportunities as they arise

See how we can help you get ahead in the competitive medtech environment: watch the video

Relevant products

Medtech Insight: global medical technology news & analysis

You’ll instantly connect to the latest in global medtech developments with industry news, trends, deals, product developments, opinions, analysis, and context behind the headlines and more – all available at your fingertips.

Key benefits:

Real-time news and analysis
Regulatory development news
Company development news

Meddevicetracker: medical device intelligence and forecasts

In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.

Key benefits:

Real-time market intelligence
Medical device market coverage
Discover new opportunities

In Vivo: strategic insights for life sciences decision-makers

In Vivo offers comprehensive coverage of the global medical industry’s competitive landscape.

Key benefits:

Cutting edge thought leadership
Expert analysis
Hear from news makers

In Vivo

Six of the Greatest Therapeutic R and D Challenges

16 Aug 2019

Explore the six biggest therapeutic R&D challenges facing the industry today with a free infographic from In Vivo. This snapshot view of the major issues facing R&D is packed with data and insights about everything from drug resistance to diagnostics challenges.

Topic Drug development landscape

View infographic
In Vivo

MedTech Forum 2019: The Future Is Here But Industry Still Needs A Long-Term Vision

By Ashley Yeo 16 Aug 2019

In a world where national economies are beset by conflicting spending priorities, health care is oftentimes too low on the agenda, health care observers say. One of these is Boston Scientific senior vice-president Eric Thépaut, who understands the dilemmas, but says that health care will soon force its way up the priority list. He has advice for future-ready medtech innovators.

Topic Medtech Business strategies

View article
Medtech Insight

Compliance Corner: FDA Investigator Sees These 4 Common Sterilization Problems When Inspecting Facilities

By Shawn M. Schmitt 14 Aug 2019

Phil Pontikos, who is also the US agency's national device expert, explains how device-makers can avoid running afoul of the FDA's rules and expectations for sterilization activities.

Topic FDA

View article
Medtech Insight

CMS Weighs Merits Of New Pass-Through Payments For Aquabeam System, Eluvia Stents In OPPS Proposal

By Sue Darcey 14 Aug 2019

The US Medicare agency has been scrutinizing two new devices that have generated some buzz within the industry for pass-through payment status under its proposed 2020 Outpatient Prospective Payment System (OPPS) rules. The devices are Procept BioRobotic’s AquaBeam System for removal of prostate tissue in men with urinary tract symptoms, and Boston Scientific’s Eluvia drug-eluting stent for treatment of peripheral artery disease.

Topic Medtech

View article
In Vivo

Could The Gut Cure Brain Disease?

By Melanie Senior 08 Aug 2019

Scientists now understand that there are multiple, bi-directional links between gut and brain. They are using this knowledge to develop new treatments for some of the most challenging chronic conditions, including Alzheimer’s disease, Parkinson’s disease and obesity.

Topic Diseases

View article
Medtech Insight

US and EU Guidance Report

06 Aug 2019

US FDA says as artificial intelligence and machine learning offer new opportunities to improve patient care, the agency hopes to encourage innovation by developing a draft guidance on the issue for sponsors. It also released a discussion paper outlining key issues it wants feedback on from industry and other key stakeholders.

Topic FDA Digital Health Medtech

Single report
Medtech Insight

Exact Sciences Buys Genomic Health In $2.8Bn Expansion Deal

By Catherine Longworth 06 Aug 2019

Cancer diagnostics company Exact Sciences is combining with Genomic Health in a major merger valued at $2.8bn. The combined company will offer two of the fastest growing brands in cancer diagnostics, Cologuard and Oncotype DX.

Topic Cancer Business strategies

View article
Meddevicetracker

Introducing Meddevicetracker's Market Analysis Tool

02 Aug 2019

Find and manipulate the essential medical devices and diagnostics market intelligence you rely on from Meddevicetracker’s Market Analysis Reports with Meddevicetracker’s new interactive Market Analysis tool.

Topic Strategy Business strategies Company analysis

View white paper
In Vivo

Meet the 2019 Titans of Pharma

31 Jul 2019

Get exclusive info on the leaders of the Pharma industry.The 2019 Titan of Pharma infographic is a snapshot of the industry’s top leaders and the businesses they oversee.

Topic Company analysis Strategy

View infographic
Medtech Insight

Market Brief: The Need For Safer Needles, Syringes Will Drive Global Injection Devices Market Growth By 2023

By Marion Webb 30 Jul 2019

Accelerating technological innovation, reimbursement and legislative changes are expected to make a significant impact on the global market of injection devices and related products. According to Informa's new Meddevicetracker report on "Infection Control and Biosafety Products," the combined market of these devices will reach $4bn by 2023.

Topic Medtech BioPharmaceutical

View article
In Vivo

How To Negotiate With Public Payers: Five Lessons - And A Few Cautions - From The UK's New Pact On Drug Price And Access

By William Looney 30 Jul 2019

In today’s globalized market for medicines, national rules on pricing and access are abundantly shared and more transparent than opaque. In Vivo speaks to the UK branded industry’s negotiator for the latest five-year joint pricing pact with the government, Richard Torbett, who outlines, among other topics, five widely applicable precedents from the talks that can work in “getting to yes” – despite the fractious budgetary climate for health care evident in all major country markets.

Topic Brexit Policy and regulation

View article
Medtech Insight

Siemens Cybersecurity Expert Says Medtech Industry Has 'Perverse Incentive' To Not Disclose Vulnerabilities – Might A New Law Be The Fix?

By Shawn M. Schmitt 26 Jul 2019

The fear of losing business by being transparent about cybersecurity vulnerabilities means there's "a perverse incentive in some parts of the market that encourages a lack of disclosure," Siemens' Harrison Wadsworth says. But the US FDA's Suzanne Schwartz believes coordinated vulnerability disclosure legislation could "level the playing field."

Topic Policy and regulation Digital Health

View article
Medtech Insight

One Small Step For US FDA, But Maybe A Giant Leap For SaMDs

By Ferdous Al-Faruque 26 Jul 2019

In a midyear update from the FDA, regulators say a retrospective review of companies in its pre-cert pilot program has concluded that evaluating a company for excellence markers could be sufficient to let Software as a Medical Device (SaMD) onto the market. However, at least one critic says the update doesn’t answer some of the most critical questions about whether the program meets the agency's own requirements and if it creates unfair advantages for certain companies.

Topic FDA Policy and regulation

View article
Scrip, In Vivo

AI in the Pharmaceutical Landscape

25 Jul 2019

AstraZeneca’s pact with the UK-based artificial intelligence leader BenevolentAI, in April 2019, is one component in a string of recent deals that have highlighted big pharma’s desire to embed AI and machine learning within the R&D process. In total, 13 such collaborations have been tracked in the past 24 months, according to the Strategic Transactions database.

Topic Digital Health Strategy Medtech

Single report
Meddevicetracker

MeddeviceTracker Q3 2019 Outlook Report

24 Jul 2019

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Strategy Research Drug development landscape Drug review

Single report

Latest headlines

In Vivo

19 Aug 2019

European Companies Are Now Being ‘Properly Funded’

Link
Medtech Insight

19 Aug 2019

Market Intel: AACC 2019 – Roundup Of The Top 5 Diagnostics Companies

Link
Medtech Insight

19 Aug 2019

FDA Approves CVRx’s Barostim Neo For Heart Failure On Expedited Pathway

Link
Medtech Insight

19 Aug 2019

Medtronic, Capital District Physicians’ Health Plan Partner To 'Gamify' Diabetes Control

Link
Medtech Insight

19 Aug 2019

Italian Notified Body IMQ Is Likely To Be Next In Line For Official Designation

Link
Medtech Insight

19 Aug 2019

Recruitment Focus Part 3: What Is Really Driving EU Medtech Regulatory Recruitment?

Link
Medtech Insight

19 Aug 2019

MTI Profile: US FDA's Second-In-Command Has Her Eye On A Tech-Forward Future

Link
Medtech Insight

19 Aug 2019

Boston Scientific Closes Multibillion-Dollar BTG Deal

Link
Medtech Insight

16 Aug 2019

Regulators Urged To Avoid ‘Conflicting’ Clinical Requirements For Drug-Device Combinations In EU

Link
Medtech Insight

16 Aug 2019

SENSE Results Support Biotronik’s DX System For Atrial Sensing Without An Atrial Lead

Link
Medtech Insight

16 Aug 2019

Ambu Settles US Defense Department False-Claims Allegations

Link
Medtech Insight

16 Aug 2019

No Pay Incentives Needed For Non-Opioid Pain Control Devices, CMS Says; Industry Disagrees

Link
In Vivo

16 Aug 2019

C-Suite Snippets: Planning For The Future Cancer Market

Link
Medtech Insight

16 Aug 2019

Pediatric Scoliosis Device Nabs HDE Approval

Link
Medtech Insight

16 Aug 2019

FDA Expands TAVR Indication To Low-Risk Patients

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Medtech Market Intelligence

Accurate expert analysis for a fragmented market

Relevant products

Below are the Product List

Medtech Insight: global medical technology news & analysis

Meddevicetracker: medical device intelligence and forecasts

In Vivo: strategic insights for life sciences decision-makers

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store